Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2015-05-31
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
NCT04002141
The Effect of Selective Oxytocin Receptor Inhibitors on Endometriosis-related Pain
NCT05382143
Endometrial Injury for Assisted Reproduction
NCT01132144
Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram
NCT00372658
Autologous Intrauterine Platelet-Rich Plasma Instillation And Endometrial Scratching for Thinned Endometrium
NCT04240860
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ibuprofen+Lorazepam
Oral ibuprofen (600 mg) + lorazepam (1 mg); one hour before endometrial scratching.
Ibuprofen 600 mg
Lorazepam 1 mg
Ibuprofen
Oral ibuprofen (600 mg) + Placebo; one hour before endometrial scratching.
Ibuprofen 600 mg
Placebo
Placebo
Placebo + Placebo; one hour before endometrial scratching.
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ibuprofen 600 mg
Lorazepam 1 mg
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being submitted to endometrial scratching/injury with a Pipelle on the first four days of the menstrual cycle.
* Not have performed endometrial scratching in the last 90 days.
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wellington P Martins, MD
Associate Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE: 36622214.5.0000.5440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.